Our problem is not shorts. Our problem is retail holders who do not know the game that shorts are playing and buy into their games, ... lose money and SP floors, as it has. Some retail holders will be financially better off being locked up and not allowed to "invest" in stocks.
I had hoped the retail would have wisened up by now about the shorts and their bots and would not fall for their game ... that would have helped the SP regain $2.50+ .... then FDA AA, followed by a partnership would have easily put it in $5+ territory ... but at this low price, we may need some luck, ... but that luck may well be part and parcel of post FDA AA approval as other investors will circle in, and take the shares out of retail holders who have no clue. A partnership to advance REVASCOR post FDA AA would HAVE TO BE in place and ready to RnR with. As otherwise it makes no sense to expect FDA AA, and not be prepated for advancing it (which needs partnership). Post FDA AA, the retail will likely sell to new serious investors' high bids instead of selling to low bids out of panic created by shorts.
Just need to pave a bit more patience now ... bearing in mind the macro factors caused post Jan 20th!!!
MSB Price at posting:
$1.71 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)